Type I Interferon Therapy Limits CNS Autoimmunity by Inhibiting CXCR3-Mediated Trafficking of Pathogenic Effector T CellsWeiwei Wang, Jun Chen, Igal Gery et al.|Cell Reports|2019Cited by 31